Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mauger

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology|April 10, 2022
Clinical and molecular implications of RGS2 promoter genetic variation in severe asthmaJuan Carlos Cardet, Donghwa Kim, Eugene R Bleecker, et al.
Respiratory Investigation|January 10, 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trialKozo Morimoto, James D Chalmers, Pierre-Régis Burgel, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2013
Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?Avraham Beigelman, Tonya S King, David Mauger, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2009
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthmaLeonard B Bacharier, Theresa W Guilbert, Robert S Zeiger, et al.
Nature Communications|December 18, 2019
The upper-airway microbiota and loss of asthma control among asthmatic childrenYanjiao Zhou, Daniel Jackson, Leonard B Bacharier, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Increased Muc5AC and Decreased Ciliated Cells in Severe Asthma Partially Restored by Inhibition of IL-4Rα ReceptorJonathan Boomer, Jiwoong Choi, Alexander Alsup, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2020
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation FrequencyMichael C Peters, David Mauger, Kristie R Ross, et al.
The New England Journal of Medicine|April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Chest|April 1, 2023
The Fungal Microbiome of the Upper Airway Is Associated With Future Loss of Asthma Control and Exacerbation Among Children With AsthmaHanshu Yuan, Zhongmao Liu, Jinhong Dong, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2025
α1-Antitrypsin Gene Variation Associates with Asthma Exacerbations and Related Health Care UtilizationVictor E Ortega, Vickram Tejwani, Abhishek Kumar Shrivastav, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology|April 10, 2022
Clinical and molecular implications of RGS2 promoter genetic variation in severe asthmaJuan Carlos Cardet, Donghwa Kim, Eugene R Bleecker, et al.
Respiratory Investigation|January 10, 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trialKozo Morimoto, James D Chalmers, Pierre-Régis Burgel, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2013
Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?Avraham Beigelman, Tonya S King, David Mauger, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2009
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthmaLeonard B Bacharier, Theresa W Guilbert, Robert S Zeiger, et al.
Nature Communications|December 18, 2019
The upper-airway microbiota and loss of asthma control among asthmatic childrenYanjiao Zhou, Daniel Jackson, Leonard B Bacharier, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Increased Muc5AC and Decreased Ciliated Cells in Severe Asthma Partially Restored by Inhibition of IL-4Rα ReceptorJonathan Boomer, Jiwoong Choi, Alexander Alsup, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2020
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation FrequencyMichael C Peters, David Mauger, Kristie R Ross, et al.
The New England Journal of Medicine|April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Chest|April 1, 2023
The Fungal Microbiome of the Upper Airway Is Associated With Future Loss of Asthma Control and Exacerbation Among Children With AsthmaHanshu Yuan, Zhongmao Liu, Jinhong Dong, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2025
α1-Antitrypsin Gene Variation Associates with Asthma Exacerbations and Related Health Care UtilizationVictor E Ortega, Vickram Tejwani, Abhishek Kumar Shrivastav, et al.
Pageof 7